Clinical Trials
3
Active:1
Completed:2
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)β’ Click on a phase to view related trials
Phase 2
2 (100.0%)REDUCER-I: An Observational Study of the Neovasc Reducerβ’ System
Active, not recruiting
- Conditions
- Chronic Stable AnginaAngina PectorisAngina Pectoris, Stable
- First Posted Date
- 2016-03-16
- Last Posted Date
- 2025-01-01
- Lead Sponsor
- Neovasc Inc.
- Target Recruit Count
- 400
- Registration Number
- NCT02710435
- Locations
- π¦πΉ
University of Graz, Graz, Austria
π§πͺZNA Middelheim Hospital, Antwerpen, Belgium
π§πͺZienkenhuis Oost-Limburg, Genk, Belgium
Coronary Sinus Reducer for Treatment of Refractory Angina - COSIRA
Phase 2
Completed
- Conditions
- Refractory Angina
- First Posted Date
- 2010-09-21
- Last Posted Date
- 2013-11-25
- Lead Sponsor
- Neovasc Inc.
- Target Recruit Count
- 104
- Registration Number
- NCT01205893
- Locations
- π§πͺ
ZNA Middelheim Hospital, Antwerpen, Belgium
π§πͺZiekenhuis Oost-Limburg, Genk, Belgium
π¨π¦Ottawa Heart Institute, Ottawa, Ontario, Canada
Evaluation of the Metricath Gemini System, a Device Intended to Make Arterial Measurements and Perform Angioplasty Dilations.
Phase 2
Completed
- Conditions
- Angioplasty
- First Posted Date
- 2006-11-15
- Last Posted Date
- 2009-05-13
- Lead Sponsor
- Neovasc Inc.
- Target Recruit Count
- 145
- Registration Number
- NCT00399646
- Locations
- πΊπΈ
UC Irvine Medical Center, Orange, California, United States
πΊπΈMercy Heart Institute, Sacramento, California, United States
πΊπΈPasco Cardiology Center, Hudson, Florida, United States
News
No news found